Metabolic Modeling Tutorial
discounted EARLY registration ends Dec 31, 2014
Metabolic Modeling Tutorial
discounted EARLY registration ends Dec 31, 2014
Metabolic Modeling Tutorial
discounted EARLY registration ends Dec 31, 2014
Metabolic Modeling Tutorial
discounted EARLY registration ends Dec 31, 2014
Metabolic Modeling Tutorial
discounted EARLY registration ends Dec 31, 2014
twitter

MetaCyc Enzyme: inositol polyphosphate 5-phosphatase OCRL1

Gene: OCRL Accession Number: HS04546 (MetaCyc)

Synonyms: INPP5F, OCRL1, LOCR, Lowe oculocerebrorenal syndrome protein, oculocerebrorenal syndrome of Lowe

Species: Homo sapiens

Summary:
General Background

The signalling activities of both D-myo-inositol (1,4,5)-trisphosphate and D-myo-inositol (1,3,4,5)-tetrakisphosphate are terminated by hydrolysis of their 5-phosphate groups. The inositol polyphosphate 5-phosphatases have been subdivided into four subgroups based on their size and substrate specificity [Jefferson97, Erneux98].

Type I enzymes hydrolyze only the water soluble D-myo-inositol (1,4,5)-trisphosphate and D-myo-inositol (1,3,4,5)-tetrakisphosphate [Verjans94, Laxminarayan94].

Type II enzymes also accept the insoluble phospholipids 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate and a 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate as substrates [Jefferson95, Jackson95].

Type III enzymes hydrolyze only phosphoinositides and inositol polyphosphates that have a 3-position phosphate group, such as 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate [Jackson95].

Type IV enzymes hydrolyze 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate, 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate, and a 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate D-myo-inositol (1,3,4,5)-tetrakisphosphate [Jefferson97]. They do not accept water soluble cyclitols [Kisseleva00].

About This Protein

Mutations linked to the disease oculocerebrorenal syndrome of Lowe (a rare X-linked disorder characterized by mental retardation, congenital cataracts, and Fanconi syndrome of the proximal renal tubules) led to the identification of the OCRL gene on the chromosomal region Xq25-26 [Nussbaum97, Leahey93]. The encoded protein, which is highly homologous to INPP5B [Attree92], was expressed in baculovirus-infected Sf9 insect cells and found to catalyze the reactions of a type II phospatidylinositol polyphosphate 5-phosphatase [Zhang95a].

The OCRL protein has been found in the Golgi complex in fibroblasts [OlivosGlander95] and in lysosomes in kidney proximal tubule cell lines of a patient with Lowe syndrome [Zhang98e].

Locations: Golgi vesicle

Map Position: [125,520,032 -> 125,572,317]

Molecular Weight of Polypeptide: 104.2 kD (from nucleotide sequence)

Unification Links: Entrez-Nucleotide:M88162 , Entrez-Nucleotide:S62085 , Entrez-Nucleotide:U57627 , Mint:MINT-5004450 , PhosphoSite:Q01968 , Pride:Q01968 , Protein Model Portal:Q01968 , SMR:Q01968 , String:Q01968 , UniProt:Q01968

Relationship Links: InterPro:IN-FAMILY:IPR000198 , InterPro:IN-FAMILY:IPR000300 , InterPro:IN-FAMILY:IPR005135 , InterPro:IN-FAMILY:IPR008936 , PDB:Structure:2KIE , PDB:Structure:2QV2 , PDB:Structure:3QBT , PDB:Structure:3QIS , Pfam:IN-FAMILY:PF00620 , Pfam:IN-FAMILY:PF03372 , Prosite:IN-FAMILY:PS50003 , Prosite:IN-FAMILY:PS50238 , Smart:IN-FAMILY:SM00128 , Smart:IN-FAMILY:SM00324

Gene-Reaction Schematic: ?

GO Terms:

Cellular Component: GO:0005798 - Golgi-associated vesicle

Credits:
Created 19-Oct-2009 by Caspi R , SRI International


Enzymatic reaction of: phosphatidylinositol-4,5-bisphosphate 5-phosphatase (inositol polyphosphate 5-phosphatase OCRL1)

EC Number: 3.1.3.36

a 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O <=> a 1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate

The reaction direction shown, that is, A + B ↔ C + D versus C + D ↔ A + B, is in accordance with the Enzyme Commission system.

The reaction is physiologically favored in the direction shown.

In Pathways: 3-phosphoinositide degradation


Enzymatic reaction of: D-myo-inositol (1,4,5)-trisphosphate 5-phosphatase (inositol polyphosphate 5-phosphatase OCRL1)

EC Number: 3.1.3.56

D-myo-inositol (1,4,5)-trisphosphate + H2O <=> D-myo-inositol (1,4)-bisphosphate + phosphate

The reaction direction shown, that is, A + B ↔ C + D versus C + D ↔ A + B, is in accordance with the Enzyme Commission system.

The reaction is physiologically favored in the direction shown.

In Pathways: superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism , D-myo-inositol (1,4,5)-trisphosphate degradation


Enzymatic reaction of: phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase (inositol polyphosphate 5-phosphatase OCRL1)

EC Number: 3.1.3.86

1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O <=> a 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate

The reaction direction shown, that is, A + B ↔ C + D versus C + D ↔ A + B, is in accordance with the Enzyme Commission system.

The reaction is physiologically favored in the direction shown.

In Pathways: 3-phosphoinositide degradation


Enzymatic reaction of: inositol-1,3,4,5-tetrakisphosphate 5-phosphatase (inositol polyphosphate 5-phosphatase OCRL1)

EC Number: 3.1.3.56

D-myo-inositol (1,3,4,5)-tetrakisphosphate + H2O <=> D-myo-inositol (1,3,4)-trisphosphate + phosphate

The reaction direction shown, that is, A + B ↔ C + D versus C + D ↔ A + B, is in accordance with the Enzyme Commission system.

The reaction is physiologically favored in the direction shown.

In Pathways: superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism , D-myo-inositol (1,3,4)-trisphosphate biosynthesis , 1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)

Exons/Introns:


References

Attree92: Attree O, Olivos IM, Okabe I, Bailey LC, Nelson DL, Lewis RA, McInnes RR, Nussbaum RL (1992). "The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase." Nature 358(6383);239-42. PMID: 1321346

Erneux98: Erneux C, Govaerts C, Communi D, Pesesse X (1998). "The diversity and possible functions of the inositol polyphosphate 5-phosphatases." Biochim Biophys Acta 1436(1-2);185-99. PMID: 9838104

Jackson95: Jackson SP, Schoenwaelder SM, Matzaris M, Brown S, Mitchell CA (1995). "Phosphatidylinositol 3,4,5-trisphosphate is a substrate for the 75 kDa inositol polyphosphate 5-phosphatase and a novel 5-phosphatase which forms a complex with the p85/p110 form of phosphoinositide 3-kinase." EMBO J 14(18);4490-500. PMID: 7556092

Jefferson95: Jefferson AB, Majerus PW (1995). "Properties of type II inositol polyphosphate 5-phosphatase." J Biol Chem 270(16);9370-7. PMID: 7721860

Jefferson97: Jefferson AB, Auethavekiat V, Pot DA, Williams LT, Majerus PW (1997). "Signaling inositol polyphosphate-5-phosphatase. Characterization of activity and effect of GRB2 association." J Biol Chem 272(9);5983-8. PMID: 9038219

Kisseleva00: Kisseleva MV, Wilson MP, Majerus PW (2000). "The isolation and characterization of a cDNA encoding phospholipid-specific inositol polyphosphate 5-phosphatase." J Biol Chem 275(26);20110-6. PMID: 10764818

Laxminarayan94: Laxminarayan KM, Chan BK, Tetaz T, Bird PI, Mitchell CA (1994). "Characterization of a cDNA encoding the 43-kDa membrane-associated inositol-polyphosphate 5-phosphatase." J Biol Chem 269(25);17305-10. PMID: 8006039

Leahey93: Leahey AM, Charnas LR, Nussbaum RL (1993). "Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe." Hum Mol Genet 2(4);461-3. PMID: 8504307

Lecompte08: Lecompte O, Poch O, Laporte J (2008). "PtdIns5P regulation through evolution: roles in membrane trafficking?." Trends Biochem Sci 33(10);453-60. PMID: 18774718

Nussbaum97: Nussbaum RL, Orrison BM, Janne PA, Charnas L, Chinault AC (1997). "Physical mapping and genomic structure of the Lowe syndrome gene OCRL1." Hum Genet 99(2);145-50. PMID: 9048911

OlivosGlander95: Olivos-Glander IM, Janne PA, Nussbaum RL (1995). "The oculocerebrorenal syndrome gene product is a 105-kD protein localized to the Golgi complex." Am J Hum Genet 57(4);817-23. PMID: 7573041

Rohde02: Rohde G, Wenzel D, Haucke V (2002). "A phosphatidylinositol (4,5)-bisphosphate binding site within mu2-adaptin regulates clathrin-mediated endocytosis." J Cell Biol 158(2);209-14. PMID: 12119359

Verjans94: Verjans B, De Smedt F, Lecocq R, Vanweyenberg V, Moreau C, Erneux C (1994). "Cloning and expression in Escherichia coli of a dog thyroid cDNA encoding a novel inositol 1,4,5-trisphosphate 5-phosphatase." Biochem J 300 ( Pt 1);85-90. PMID: 8198557

Zhang07b: Zhang Y, Zolov SN, Chow CY, Slutsky SG, Richardson SC, Piper RC, Yang B, Nau JJ, Westrick RJ, Morrison SJ, Meisler MH, Weisman LS (2007). "Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice." Proc Natl Acad Sci U S A 104(44);17518-23. PMID: 17956977

Zhang95a: Zhang X, Jefferson AB, Auethavekiat V, Majerus PW (1995). "The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase." Proc Natl Acad Sci U S A 92(11);4853-6. PMID: 7761412

Zhang98e: Zhang X, Hartz PA, Philip E, Racusen LC, Majerus PW (1998). "Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate." J Biol Chem 273(3);1574-82. PMID: 9430698


Report Errors or Provide Feedback
Please cite the following article in publications resulting from the use of MetaCyc: Caspi et al, Nucleic Acids Research 42:D459-D471 2014
Page generated by SRI International Pathway Tools version 18.5 on Thu Nov 27, 2014, BIOCYC14B.